⌘K

Login Start Free

Home/Filings/4/0001600620-25-000076

4//SEC Filing

Goetz Kathleen 4

Accession 0001600620-25-000076

CIK 0001600620other

View on SEC.gov Company Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 5:04 PM ET

Size

5.1 KB

Accession

0001600620-25-000076

Insider Transaction Report

Form 4

Period: 2025-05-16

Aurinia Pharmaceuticals Inc.AUPH

Director

Transactions

Award
Director Stock Option (right to buy)
2025-05-16+63,724→ 63,724 total
Exercise: $8.15Exp: 2035-05-16→ Common Shares (63,724 underlying)

Footnotes (1)

[F1]The options shall vest one year from date of grant.

Documents

1 file

4
wk-form4_1747429477.xmlPrimary
FORM 4

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1

filerCIK 0001896369

Filing Metadata

Form type: 4
Filed: May 15, 8:00 PM ET
Accepted: May 16, 5:04 PM ET
Size: 5.1 KB

View on SEC.gov